AVIR

AVIR Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc. · NASDAQ
Market Closed
3.93
▼ ⁦-1.50%⁩ (-0.06)
Post-market3.930.00% (0.00)
Market Cap$315.6M
Beta0.28
52w Low52w High
2.906.45
Last Week
⁦-6.65%⁩
Last Month
⁦-3.68%⁩
Last 3 Months
⁦-27.62%⁩
Last Year
⁦+28.43%⁩
Open on chart
Premium content
Fair Value
Current price⁦$3.93⁩
  • Analyst targetsLow confidence
    2 analysts
    ⁦$7⁩
    ⁦+78%⁩
    Typical for this method across large companies: ⁦+16%⁩

10-year US Treasury yield ⁦5.10%⁩ as of ⁦2026-11-17⁩. Estimates computed from company data and analyst targets, not investment advice.

Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$700 / yr
Monthly plan
$99 / mo
Premium content
Financial Analysis
Related News

Frequently Asked Questions

What is Atea Pharmaceuticals, Inc. stock?▼

Atea Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Atea Pharmaceuticals, Inc.?▼

You can buy Atea Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Atea Pharmaceuticals, Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Atea Pharmaceuticals, Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Atea Pharmaceuticals, Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.